Great Point Partners Investor

Great Point Partners, LLC is a private equity firm specializing in growth capital investments, PIPE transactions, and industry consolidation in later stage companies. It also seeks to provide private equity for shareholder liquidity, growth recapitalizations, leveraged buyouts, management buyouts, spin-off transactions, debt restructurings, and tuck-in acquisitions. The firm makes investments in biotechnology and life sciences, biopharmaceutical infrastructure, biopharmaceutical services and supplies, consumer health, generic drugs, health care services, healthcare information technology enabled services, insurance, medical devices and diagnostics, specialty pharmaceuticals, pharmaceutical infrastructure, behavioral health, biologics manufacturing, hospital outsourcing, media and reagents, rehabilitation, workers compensation companies, and other growth areas of the healthcare sector. The firm invests in the United States, Canada, and Western Europe. It seeks to invest between $7 million and $50 million in companies with revenue between $10 million and $100 million and EBITDA between $2 million and $12 million. The firm also makes convertible debt investments and manages hedge funds for its clients. Great Point Partners, LLC was co-founded in 2003 and is based in Greenwich, Connecticut.
Technology: N/A
Industry: Precision Medicine
Headquarters: Greenwich, Connecticut, United States
Founded Date: 2003
Employees Number: 11-50
Funding Status: undisclosed
Investor Type: Venture Capital
Investment Stage: Early Stage Venture, Post-Ipo, Private Equity
Number Of Exits: 13

Visit Website
inquiries@gppfunds.com
https://twitter.com/gppfunds
Register and Claim Ownership